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Schistosomiasis,  a chronic  disease  that  affects  million  people  worldwide,  is  caused  by  trematode
ﬂukes  of  the  genus  Schistosoma.  The  lack  of an  anti-schistosomiasis  vaccine  and massive  monother-
apy  with  praziquantel  reinforces  the need  for search  and  development  of  new  therapeutic  drugs.
Recently,  we  demonstrated  that  the  essential  oil  of Piper  cubeba  L., Piperaceae,  and  their  derivative  diben-
zylbutyrolactolic  (−)-6,6′-dinitrohinokinin,  presents  in  vitro  and  in  vivo activities  against  Schistosoma
mansoni. Here,  we identiﬁed  changes  in  the  protein  expression  after  exposure  to  dibenzylbutyrolac-
tolic  (−)-6,6′-dinitrohinokinin.  We  applied  two-dimensional  gel  electrophoresis  (2-DE)  to S.  mansoni
soluble  protein  extracts  and  observed  at least 38  spots  to  be  affected  by dibenzylbutyrolactolic  (−)-
6,6′-dinitrohinokinin.  We  further  identiﬁed  25 differentially  expressed  proteins  by mass  spectrometry.
Enrichment  for  biological  processes  and  predictive  analyses  of  protein-protein  interactions  suggest  thatchistosoma mansoni
wo-dimensional gel electrophoresis dibenzylbutyrolactolic  (−)-6,6′-dinitrohinokinin  targets  proteins  involved  mainly  in metabolic  processes,
especially  carbohydrate  metabolism.  In summary,  this  study  provides  an  interesting  approach  to under-
stand  the anti-parasitic  activity  of  semi-synthetic  (−)-6,6′-dinitrohinokinin  a  derivative  compound  from
lignan  and  for  the  development  of  new  therapy  strategies.
©  2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Schistosomiasis is caused by a parasitic infection with trema-
ode ﬂukes of the genus Schistosoma and affects more than 200
illion people worldwide (Rollinson et al., 2013). Currently, an
ntischistosomal vaccine is not available, whereas Praziquantel
PZQ) is the drug of choice for the treatment of patients (Caffrey,
015). Although PZQ have been effective in the treatment of the
isease, the possibility of drug resistance caused by repeated and
assive monotherapy reinforces the need to develop new safe andffective drugs for the prevention and treatment against schistoso-
iasis (Cioli et al., 2014; Colley et al., 2014).
∗ Corresponding author.
E-mail: lizandra.magalhaes@unifran.edu.br (L.G. Magalhães).
http://dx.doi.org/10.1016/j.bjp.2016.02.001
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraPiper cubeba L., Piperaceae, known as the tailed pepper, has
been used in traditional medicine for the treatment of dysen-
tery, syphilis, abdominal pain, diarrhea, enteritis and asthma (Usia
et al., 2005; Gutierrez et al., 2013). We  demonstrated previously
that extracts and isolated compounds from Piper species present
anti-parasitic activity (Saraiva et al., 2007, 2010; Esperandim
et al., 2013). Furthermore, we  showed that the essential oil of
P. cubeba and their derivative dibenzylbutyrolactolic (−)-6,6′-
dinitrohinokinin (1, DNH), presents in vitro and in vivo activities
against Schistosoma mansoni (Magalhães et al., 2012; Pereira et al.,
2015).
High-throughput strategies including genomics, transcrip-
tomics, proteomics and metabolomics have become important
approaches to understand schistosome biology and pathogenesis,
but also constitute important tools to the exploration of novel
drugs, vaccines or diagnosis (De Marco and Verjovski-Almeida,
2009; Chuan et al., 2010). In view of these facts, we  identiﬁed
 Ltda. All rights reserved.
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age, a mass/charge exclusion list was  maintained so that the same
peptide was  not selected for MS/MS  within a period of 40 s. The col-
lision energy used for peptide fragmentation was varied according
to the mass and charge of the ion.L.G. Magalhães et al. / Revista Brasile
hanges in the protein expression induced by exposure to DNH.
e applied a strategy based on two-dimensional gel electrophore-
is (2-DE) followed by mass spectrometry, which provided insights
nto key proteins, molecular functions and biological processes tar-
eted by DNH.
aterials and methods
btainment of DNH
Prior to the DNH synthesis, (−)-cubebin (2) was isolated
rom Piper cubeba L., Piperaceae,  seeds and (−)-hinokinin (3) was
btained by oxidation of (−)-cubebin (Da Silva et al., 2005). (−)-
inokinin was then submitted to a nitration reaction in the
resence of fuming HNO3. The reaction was processed under mag-
etic stirring at 0 ◦C for 2 h. The obtained DNH (1) was crystallized as
ellowish powder from MeOH. The purity of the synthesized DNH
as estimated to be higher than 95% by both HPLC and 1H and 13C
MR  analyses, as well as by its melting point (Setchell et al., 1981;
osta, 2000).
Yield 97.6%; []D25 −29.07◦ (c 0.008, CHCl3, ee > 99%); mp
91–193 ◦C; 1H NMR  (300 MHz, CDCl3) ı 7.5 (s, 1H); ı 7.48 (s, 1H);
 6.8 (s, 1H); ı 6.6 (s, 1H); ı 6.1 (m,  2H); ı 4.35 (dd, 1H, J = 7.1 Hz
nd J = 9.1 Hz); ı 4.0 (dd, 1H, J = 7.3 Hz and J = 9.1 Hz); ı 3.26 (d, 2H,
 = 7.1 Hz); ı 3.2 (dd, 1H, J = 6.3 Hz and J = 13.6 Hz); ı 3.0 (dd, 1H,
 = 7.8 Hz and J = 13.6 Hz); ı 2,8 (m,  2H); 13C NMR  (75 MHz, CDCl3):
78.0, 152.3, 152.2, 147.6, 143.1, 142.9, 130.9, 130.7, 112.5, 111.2,
06.6, 106.2, 103.6, 103.5, 71.4, 45.7, 41.7, 37.2, 34.21.
arasite strain
The LE (Luiz Evangelista) strain of S. mansoni was maintained
y passage through Biomphalaria glabrata snails and BALB/c mice.
fter 49 ± 2 days, S. mansoni adult worms were recovered under
septic conditions from mice previously infected with 200 cer-
ariae by perfusion of their livers and mesenteric veins (Smithers
nd Terry, 1965). Experiments were approved by Animal Research
thics Committee from Ribeirão Preto Medical School – University
f São Paulo, under the protocol 021/2009.
. mansoni soluble protein extraction and two-dimensional
olyacrylamide gel electrophoresis (2-DE)
Parasites exposed to 25 M DNH or RPMI 1640 medium (0.1%
MSO) were transferred to 0.5 ml  of homogenization buffer [25 mM
ris–HCl, pH 7.5, 1 mM phenylmethanesulfonyl ﬂuoride and 1 mM
ithiothreitol] and worms  were lysed by sonication (5 × 10 s,
1 kHz at 7 m amplitude) at 10 s interval, on ice. Cellular debris
as removed from the lysate by centrifugation for 1 h at 15,000 × g,
◦C. The supernatant containing soluble proteins was  collected and
uantiﬁed using the Coomassie Protein Assay Kit (Pierce Biotech-
ology).
Soluble proteins (200 g) were dissolved in an isoelectric focus-
ng buffer [7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.5% (v/v) carrier
mpholytes (IPG buffer 3–10 l, GE Healthcare), 40 mM dithiotreitol
DTT) and 0.002% (v/v) bromophenol blue] and rehydrated into2 3  Farmacognosia 26 (2016) 334–341 335
linear 13-cm Immobiline dry strips pH 3–10 (GE  Healthcare) for
16 h at 20 ◦C. Isoelectric focusing was carried out on Ettan IPGphor
(GE Healthcare), by applying a current of 50 mA/strip, following
the steps: 1 h at 500 V (step), 1 h at 1000 V (gradient), 2.5 h at
8000 V (gradient) and 0.5 h at 8000 V (step), totaling 16 kVh. The
focused strips were equilibrated for 15 min  in 15 ml  equilibration
buffer [50 mM Tris–HCl pH 8.8, 6 M urea, 30% (v/v) glycerol, 2%
(w/v) SDS], supplemented with 1% (w/v) DTT and subsequently
for 15 min  in 15 ml  equilibration buffer with 2.5% (w/v) iodoac-
etamide. Proteins were separated in 12.5% (w/v) sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using the
Ruby 600 apparatus (GE Healthcare) and SDS electrophoresis buffer
(25 mM Tris, 192 mM glycine and 0.1% (w/v) SDS). Each gel was
performed in triplicate.
Protein visualization and image analysis
2-DE gels were ﬁxed for 1 h with 3% (v/v) phosphoric acid and
50% (v/v) ethanol, followed by staining with Coomassie Brilliant
Blue G250 (GE Healthcare) during 24 h. 2-DE protein proﬁles were
obtained after gel distaining in MilliQ water. Gels were digitized
at 300 dpi and 16 bits depth resolution with an ImageScanner (GE
Healthcare) operated by the LabScan software (GE Healthcare). The
software ImageMaster 2D Platinum 6.0 (GE Healthcare) was used to
merge the image of each experimental replicate onto a master 2-DE
gel image, using the six well-deﬁned landmark as reference to spot
detection. Differential protein expression was analyzed by compar-
ison of spot intensity in gels containing proteins from S. mansoni
exposed to DNH and unexposed controls. Spots that presented at
least 1.5-fold change in intensity given by Student’s t test (p < 0.05)
were manually excised and analyzed by mass spectrometry.
In gel digestion and identiﬁcation of proteins by liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
Spots obtained from 2-DE gels were digested with grade-
modiﬁed trypsin (Promega), as described by Shevchenko et al.
(1996). After digestion, peptides were extracted with 50% (v/v) ace-
tonitrile plus 5% (v/v) formic acid solution. The resulting peptides
were dried again and re-suspended in 12 l of 0.1% (v/v) formic acid.
An aliquot of 4.5 l of the digested protein was then separated on a
C18 RP-UPLC column (100 mm × 100 m I.D. × 1.7 m particle size,
nanoAcquity UPLC, Waters) using a linear gradient of 15–90% (v/v)
acetonitrile in 0.1% (v/v) formic acid for 10 min at 0.6 l/min. The
HPLC system was coupled to a Q-Tof Ultima API mass spectrom-
eter (MicroMass/Waters) ﬁtted with a nano-electrospray source.
The parameters were 35 V cone voltage, nano-electrospray volt-
age was  3.5 kV, and 100 ◦C source temperature. The equipment was
operated in the MS  positive ion mode, with continuous data acqui-
sition from a mass-to-charge ratio (m/z) 100–2000 Da, at a scan
rate of 1 s and an interscan delay of 0.1 s, which was followed by
MS/MS  of the three most intense ions. To optimize peptide cover-1
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Dig. 1. Effect of (−)-6,6 -dinitrohinokinin on Schistosoma mansoni adult protein pr
nd  after exposure to 25 M DNH (B). Numbers represent 38 spots whose intensity
The data obtained were processed using Mascot Distiller
.2.3.2.0 (Matrix Science Ltd.) and proteins were identiﬁed by
orrelation of tandem mass spectra against public available S. man-
oni (27,729 sequences and 12,093,356 residues) deposited into
CBI database. Search parameters for MASCOT were as follows: S.
ansoni taxonomic restriction; trypsin cleavage, one missed cleav-
ge; carbamidomethyl–cys as ﬁxed modiﬁcation (monoisotopic
ass 57.0215 Da), methionine oxidation as variable modiﬁcation
monoisotopic mass 15.9949) carbamidomethyl (C); variable mod-
ﬁcation, oxidation (M); peptide tolerance, 0.1 Da; MS/MS  fragment
on tolerance. Results were regarded as signiﬁcant with an allowed
ikelihood for a random hit of p < 0.05, according to the MAS-
OT.
ioinformatic analysis
Identiﬁed proteins were analyzed for Gene Ontology (GO)
nrichment and protein class using the bioinformatics tools PAN-
HER (Mi  et al., 2013) and UniProt (Consortium, 2014). The
etworks of interaction for the identiﬁed proteins were performed
sing STRING database v 9.05, employing prediction meth-
ds as neighborhood, gene fusion, co-occurrence, co-expression,
xperiments, database and textmining sources (Jensen et al.,
009). We  performed analysis in both Cluster of Orthologous
roups/Eukaryotic Orthologous Groups (COG/KOG) (with a high
onﬁdence of 0.700) and PROTEIN-modes (with a medium con-
dence of 0.400). The identity of the putative proteins were
onsidered signiﬁcant if they presented at least 75% of homology
ith sequences from Schistosoma japonicum.
esults
Differential protein analyses revealed approximately 38 spots
i.e., proteins) that were signiﬁcantly affected by 25 M DNH
Fig. 1A and B). Most of the separated proteins have molecular
eights greater than 25 kDa and are distributed among the isoelec-
ric points from 4 to 10. Basic proteins (i.e., proteins that present
n isoelectric point from 8 to 10) were directly affected by expo-
ure to DNH, which resulted in their absence or lower expression.
lthough, we observed that spots numbered as 4, 8, 9, 19, 35, 36,
7 and 38 are present in protein proﬁle of S. mansoni unexposed to
NH, these spots were not identiﬁed after drug exposure (Fig. 1Aomparative bidimensional gels analyses of S. mansoni soluble proteins before (A)
igniﬁcantly affected (p < 0.05) by DNH.
and B). After exposure to DNH, the spots 2, 5, 10, 11, 17, 18 and 21
were present or had at least a 2-fold increase in expression, while
nineteen proteins had at least a 2-fold reduction or no expression
(Fig. 1A and B).
To gain further knowledge on changes of protein expression
by S. mansoni after exposure to DNH, we performed LC-MS/MS.
For each spectrum, a search for protein sequences from S. mansoni
was performed with MASCOT at NCBI nr protein database (27,729
sequences and 12,093,356 residues). We  further identiﬁed 25 dif-
ferentially expressed proteins by mass spectrometry, however,
twenty four identiﬁed proteins had MASCOT scores higher than 28
(p < 0.05) and only one protein spot (spot n◦ 19) had MASCOT score
below 28 (p > 0.05) (Table 1). Of interest, the tegumental antigen Sm
20.8 and phosphoglycerate mutase (spots 10 and 11, respectively)
were expressed following exposure to DNH, whereas the peroxire-
doxin, gelsolin and a major egg antigen (spots numbered as 5, 17
and 18, respectively) were the proteins with the highest expres-
sion after exposure to DNH (Fig. 1A and B, and Table 1). Notably,
exposure to DNH decreased the expression of the peptidyl-prolyl
cis-trans isomerase, glutathione-S-transferase (GST), 14-3-3 pro-
tein, 14-3-3 epsilon, calreticulin and paramyosin (spots numbered
as 1, 12, 13, 14, 28 and 32, respectively) (Fig. 1A and B, and Table 1).
MASCOT did not retrieve signiﬁcant matches to spots 3, 4, 16, 20,
21, 24, 25, 26, 27, 30, 33, 34 and 36, therefore we were unable to
identify their protein content (Fig. 1).
To evaluate which biological processes might be affected by
exposure to DNH, we  performed a predictive functional analy-
sis with public available tools as PANTHER classiﬁcation system
and UniProt. S. mansoni adult proteins were mainly enriched in
Gene Ontology (GO) biological processes such as: metabolic pro-
cess (45.5%), cellular process (22.7%), localization (13.6%), biological
regulation (9.1%) and cellular component organization or biogen-
esis (9.1%) (Fig. 2A and Table 2). Furthermore, enrichment by GO
molecular function resulted in 52.9% of proteins enriched in cat-
alytic activity, followed by proteins related to binding (17.6%),
enzyme regulator activity (11.8%), structural molecule activity
(11.8%) and antioxidant activity (5.9%) (Fig. 2B and Table 2). In addi-
tion, proteins enriched in Panther protein class resulted in 20% of
oxidoreductases, 13.3% of isomerases, 13.3% enzyme modulators,
13.3% of cytoskeletal proteins, chaperones, 6.7% of calcium-binding
proteins, 6.7% of kinases, 6.7% of lyases and 6.7% of transferases
(Fig. 2C).
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Table  1
Schistosoma mansoni adult proteins identiﬁed by LC-MS/MS.
Spot n◦ Protein name Accession numbera MW (kDa)/pI MW (kDa)
experimental
Coverage %c Mascot Scored Expression after
exposure DNHe
1 Peptidyl-prolyl cis-trans
isomerase
Smp  040130 18/8.26 12 46 390 Down
2  Nucleoside diphosphate kinase Smp  092750 17/7.74 10 79 453 Up
5  Peroxiredoxin, Prx1 Smp  059480 21/6.10 18 36 231 Up
6  Calponin-related Smp  086330 21/8.68 17 55 453 Down
7  Putative adenylate kinase Smp  071390 22/8.52 19 45 331 Down
8  Triosephosphate isomerase Smp 003990 28/4.63 22 54 481 Down
9  Putative carbonyl reductase Smp  033540 31/7.64 24 2 37 Down
10  Putative tegumental antigen
Sm20.8
Smp  086530 21/6.90 23 56 196 Up
11  Phosphoglycerate mutase Smp  096760 28/7.71 22 50 234 Up
12  Glutathione S-transferase Smp  054160 24/6.56 22 16 132 Down
13  14–3-3 protein, putative Smp 009760 28/4.74 23 46 553 Down
14  14–3-3 epsilon Smp  034840 28/4.85 25 52 354 Down
15  Camp-dependent protein
kinase type II-alpha regulatory
subunit
Smp  079010 43/5.12 32 33 286 Down
17  Putative gelsolin Smp  008660 42/5.57 34 46 433 Up
18  Putative major egg antigen Smp  049300 39/6.23 33 18 287 Up
19  Putative four and A half lim
domain
Smp 048560 32/7.61 26 14 20 Down
22  Malate dehydrogenase Smp  047370 37/8.70 34 31 746 Down
23  Glyceraldehyde-3-phosphate
dehydrogenase
Smp 056970 37/8.16 36 32 305 Down
28  Calreticulin autoantigen
homolog, putative
Smp  030370 45/4.69 49 39 231 Down
29  Putative alpha tubulin Smp  090120 51/4.97 49 53 1416 Down
31  Putative heat shock protein Smp  072330 81/4.92 75 25 623 Down
32  Putative paramyosin Smp 021920 90/5.3 98 14 142 Down
35  Taurocyamine kinase Smp  194770 77/7.87 72 11 91 Down
37  Aconitate hydratase Smp  063090 66/8.45 74 18 88 Down
38  Putative uncharacterized
protein
Smp  042170 40/7.63 38 20 167 Down
a S. mansoni Genedb database identiﬁer.
b Predicted molecular weight (MW)  and isoelectric point (pI) recovered in the NCBI protein database and Protparam tool.
c Coverage %: The Sequence Coverage is the percentage of the database protein sequence covered by matching peptides.
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ed Score: Relative for the probability that the observed match between the experim
e Spots that changed at least 1.5-fold in intensity (down or up) after exposure to 
Next, to understand whether the identiﬁed proteins interact
ith each other and therefore contribute to common biological
rocesses, we performed predictive protein-protein interaction
nalyses using String. Analysis of differentially expressed proteins
f S. mansoni assigned to clusters of orthologous groups (COG)
r eukaryotic orthologous groups (KOG) shows that all proteins,
xcept for glutathione-S-transferase (GST) (KOG1695), might inter-
ct with one or more nodes in the predicted network (Fig. 3A). As
xpected, the network depicts an upper cluster of proteins assigned
ith COGs, while in a second cluster, the majority of nodes were
ssigned with KOG. Further analysis resulted in a more speciﬁc
etwork of potential targets induced or repressed by exposure to
NH, which possess signiﬁcant identity with proteins of S. japon-
cum (Fig. 3B). Of note, ﬁve proteins enriched in this network were
educed after exposure to DNH, while only nucleoside diphos-
hate kinase and phosphoglycerate mutase presented a signiﬁcant
ncrease in intensity when compared to unexposed controls (Fig. 1
nd Table 1).
iscussion
Here, we show that DNH modulates the proﬁle of a protein set
rom S. mansoni adult worms. Several of those proteins, affected
y exposure to DNH, participate of important metabolic processes
nd have already been exploited as potential vaccine candidates
Pearce, 2003; Kohama et al., 2010; Fonseca et al., 2012; Beaumier
t al., 2013) or for immunodiagnosis (El Aswad et al., 2011; Qian
t al., 2012; Yu et al., 2014). For example, reduced expression ofl data and the database sequence is a random event.
ompared to unexposed control.
paramyosin, a major structural component that has been associated
as potent mucosal immunogen against Schistosoma ssp. (Lanar et al.,
1986; Jiz et al., 2009; Kohama et al., 2010), might reﬂect similar
activity with the essential oil of P. cubeba and DNH by affecting
the motility of adult worms  (Magalhães et al., 2012; Pereira et al.,
2015).
Analysis of protein–protein interactions operated on COG/KOG
mode resulted in two  major clusters of interactions, whereas
proteins assigned to COG were mainly enriched in metabolic
processes, such as adenosine triphosphate (ATP) generation and
carbohydrate metabolism (Fig. 3A and Table 2). For example, S.
mansoni nucleoside diphosphate kinase (COG0105) and adenylate
kinase (COG0563) catalyze reactions that generate ATP (Senft and
Crabtree, 1983). Our results demonstrated that adenylate kinase
was decreased after exposure to DNH and suggest that the com-
pound might affect the activity of directly and thus impair the levels
of ATP. In contrast, the increased expression of nucleoside diphos-
phate kinase could be a compensatory response in view of the
low adenylate kinase activity. Furthermore, predicted interactions
of proteins mainly enriched in carbohydrate metabolism, such as
phosphoglycerate mutase (COG0588), triosephosphate isomerase
(COG0149), malate dehydrogenase (COG0039), glyceraldehyde-
3-phosphate dehydrogenase (COG00570), aconitate hydratase
(COG1048) indicate that DNH targets pathways crucial to devel-
opment and survival of S. mansoni, such as glycolysis and
gluconeogenesis (Zhou et al., 2008). This is further corroborated due
the level of agreement in protein expression, since only phospho-
glycerate mutase increased after exposure to DNH (Table 1). Indeed,
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Table 2
Enrichment analysis by Gene Ontology and PANTHER terms.
IDsa Protein (COG/KOG IDs)b GO molecular function GO biological process PANTHER protein class
Smp  040130 Peptidyl-prolyl cis-trans
isomerase (COG0652)
Isomerase activity Protein folding, Intracellular
protein transport, Nuclear
transport
Isomerase
Smp  092750 Nucleoside diphosphate kinase
(COG0105)
ATP binding CTP biosynthetic process, UTP
biosynthetic process
–
Smp  059480 Peroxiredoxin, Prx1 (COG0450) Oxidoreductase activity,
Peroxidase activity
Metabolic process Peroxidase
Smp  086330 Calponin-related (COG5199) – – –
Smp 071390 Putative adenylate kinase
(COG0563)
Nucleotide kinase activity Purine nucleobase metabolic
process, Pyrimidine nucleobase
metabolic process
Nucleotide kinase
Smp  003990 Triosephosphate isomerase
(COG0149)
Isomerase activity Glycolysis Isomerase
Smp  033540 Putative carbonyl reductase
(COG1028)
Oxidoreductase activity Steroid metabolic process Dehydrogenase
reductase
Smp  086530 Putative tegumental protein
Sm 20.8
Catalytic activity, Structural
constituent of cytoskeleton,
Protein binding, Enzyme
inhibitor activity
Nitric oxide biosynthetic process,
Nucleobase-containing compound
metabolic process, Cell cycle, RNA
localization, Intracellular protein
transport, Vesicle-mediated
transport, Regulation of catalytic
activity, Cellular component
organization
Enzyme modulator,
Microtubule family,
Cytoskeletal protein
Smp  096760 Phosphoglycerate mutase
(COG0588)
Bisphosphoglycerate
2-phosphatase activity,
Bisphosphoglycerate mutase
activity, Phosphoglycerate
mutase activity
Glycolytic process –
Smp  054160 Glutathione-S-transferase
(KOG1695)
Glutathione transferase
activity
Transferase activity –
Smp  009760 14-3-3 protein, putative
(COG5040)
Protein binding, ATP binding,
Protein domain speciﬁc
binding
Cell cycle Chaperone
Smp  034840 14-3-3 epsilon (KOG0841) Protein binding, ATP binding,
Protein domain speciﬁc
binding
Cell cycle Chaperone
Smp 079010 Camp-dependent protein
kinase type II-alpha regulatory
subunit, putative (KOG0616)
Kinase activity, Protein
binding, Kinase regulator
activity
Protein phosphorylation
Cellular process
Regulation of catalytic activity
Kinase modulator
Smp  008660 Putative gelsolin (KOG0443) Structural constituent of
cytoskeleton, Cytoskeletal
protein binding
Cellular process, Cellular
component organization or
biogenesis
Cytoskeletal protein
Smp  049300 Putative major egg antigen
(KOG3591)
– – –
Smp  048560 Putative four and A half lim
domains (KOG1704)
Zinc ion binding, Metal ion
binding
– –
Smp  047370 Malate dehydrogenase
(COG0039)
Oxidoreductase activity Generation of precursor
metabolites and energy,
Carbohydrate metabolic process,
Tricarboxylic acid cycle
Dehydrogenase
Smp  056970 Glyceraldehyde-3-phosphate
dehydrogenase (COG00570)
Glyceraldehyde-3-phosphate
dehydrogenase (NAD+)
(phosphorylating) activity,
NAD and NADP binding
Glucose metabolic process
Glycolysis
Oxidoreductase
Dehydrogenase
Smp  030370 Calreticulin autoantigen
homolog, putative (KOG0674)
Calcium ion binding Protein folding Calcium-binding
protein
Smp  090120 Putative alpha tubulin
(COG5023)
Structural constituent of
cytoskeleton
Cellular component movement,
Mitosis, Intracellular protein
transport, Cellular component
organization
Tubulin
Smp  072330 Putative heat shock protein
(COG0071)
ATP binding Protein folding Chaperone
Smp  021920 Putative paramyosin
(KOG0161)
Motor activity, Structural
constituent of cytoskeleton,
Protein binding, Enzyme
regulator activity
Metabolic process, Cytokinesis,
Cellular component movement,
Mitosis, Cell communication,
Muscle contraction, Sensory
perception of sound, Sensory
perception, Mesoderm
development, Anatomical
structure morphogenesis,
Intracellular protein transport,
Vesicle-mediated transport,
Regulation of catalytic activity,
Cellular component organization
G-protein modulator,
Actin binding motor
protein, Cell junction
protein
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Table  2 (Continued)
IDsa Protein (COG/KOG IDs)b GO molecular function GO biological process PANTHER protein class
Smp  194770 Taurocyamine kinase
(KOG3581)
ATP binding, Metal ion binding,
Oxidoreductase activity,
Taurocyamine kinase activity
Catalyzes –
Smp  063090 Aconitate hydratase
(COG1048)
Hydrolyase activity Generation of precursor
metabolites and energy,
Carbohydrate metabolic process,
Tricarboxylic acid cycle, Cellular
amino acid biosynthetic process
Dehydratase,
Hydratase
Smp 042170 Putative uncharacterized
protein (KOG1557)
– – –
a S. mansoni Genedb database identiﬁer.
b COG, cluster of orthologous groups; KOG, eukaryotic orthologous groups; GO, Gene Ontology terms; PANTHER classiﬁcation resultant from enrichment in UNIPROT and
PATHER tools.
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vig. 2. Classiﬁcation of Schistosoma mansoni adult proteins according to biological pr
unction (B) and PANTHER protein class (C) retrieved by PANTHER classiﬁcation sys
arasitic helminthes depend heavily on carbohydrate metabolism
o supply their energy demand, whereas one quarter to one third of
heir energy derives from aerobic respiration (Coles, 1973; Barrett,
009).
Evaluation of putative interactions on STRING protein mode
esulted in a distinct and smaller network (Fig. 3B). Paramyosin,
ST, triosephosphate isomerase and glyceraldehyde-3-phosphate
ehydrogenase and their reduced expression after exposure to DNH
ndicates that those proteins participate of common biological pro-
esses. Indeed, all of them were enriched in metabolic processes,
hile triosephosphate isomerase and glyceraldehyde-3-phosphate
ehydrogenase were speciﬁcally associated to glycolysis (Fig. 3B
nd Table 2). Previous study demonstrated that S. mansoni GST has a
ow level of homology with GST found in mammalians, which rein-
orces its potential as a target for development of new drugs and
accines (Taylor et al., 1988). In addition, several anthelmintics canes and molecular function. Enrichment of GO biological processes (A), GO molecular
also bind to glutathione transferases, especially those containing a
phenolic ring (Barrett, 2009).
Previous study revealed that peroxiredoxin is signiﬁcantly more
abundant after exposure to PZQ (Aragon et al., 2009), thus as
expected, we observed an increase in expression of this enzyme
after exposure to DNH. Overall, our data suggest that schistosomes
exposed to DNH may  increase the production of peroxiredoxins as a
defense mechanism against the stress and oxidative process, which
might be a common process between parasitic worms.
Acidic proteins of the 14-3-3 family are widely expressed by
S. mansoni. These proteins self-assemble spontaneously and form
phosphoserine–threonine-binding dimers that can interact with
over 70 different proteins (Tzivion and Avruch, 2002). Studies
have shown that these proteins could be involved in the regula-
tion of PKC functions during the worm development (Wiest et al.,
1992; Siles-Lucas and Gottstein, 2003). In addition, it has been
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Fig. 3. Network of interactions from Schistosoma mansoni proteins affected by
exposure to DNH. Identiﬁed S. mansoni proteins were matched to S. japonicum
on  STRING database v9.05. (A) Network of interactions on Cluster of ortholo-
gous groups/Eukaryotic orthologous groups (COG/KOG) mode. (B) Network of
interactions on protein mode; nucleoside diphosphate kinase, adenylate kinase, glu-
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P.,  Roth, A., Simonovic, M.,  Bork, P., von Mering, C., 2009. STRING 8 – a globalathione S-transferase, glyceraldehyde-3-phosphate dehydrogenase, paramyosin,
riosephosphate isomerase, phosphoglycerate mutase.
ound that 14-3-3 epsilon interacts with the intra-cytoplasmic
hosphorylated S. mansoni receptor kinase-1, but also binds to
nd modulate the activity of human trans-forming growth fac-
or  receptor-1 (TRI) (McGonigle et al., 2001; Siles-Lucas and
ottstein, 2003).
Tegumental antigens mediate several signaling and transport
rocesses, such as the regulation of calcium levels and control of
uscle contraction (Mohamed et al., 1998). Therefore, these pro-
eins represent potential targets to new therapy compounds and
accines (Fonseca et al., 2012). DNH may  also act on parasite struc-
ure, since we observed a high expression of the tegumental antigen
m20.8 in response to DNH. This hypothesis is further corroborated
y the increased expression of gelsolin that has been associated
ith inhibition of cell apoptosis by blocking mitochondrial mem-
rane loss and preventing the release of cytochrome C (Koya et al.,
000). Indeed, tegumental antigen Sm20.8, gelsolin, calponin, alpha
ubulin and paramyosin are proteins particularly important for
he organization of the syncytial tegument of schistosomes and
ave a signiﬁcant role in host-parasite interactions (Jones et al.,
004). Farmacognosia 26 (2016) 334–341
Overall, our study adds new knowledge into the understand-
ing of anti-schistosomicidal activity of semi-synthetic (−)-6,6′-
dinitrohinokinin a derivative compound from lignan and raises new
perspectives for future therapeutic approaches.
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